|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
RU2013109251A
(ru)
|
2010-08-04 |
2014-09-10 |
Томас Джулиус БОРОДИ |
Композиции для трансплантации фекальной флоры и способы их получения и применения и устройства для их доставки
|
|
EP3610881A1
(en)
|
2011-03-09 |
2020-02-19 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
US10220089B2
(en)
|
2012-08-29 |
2019-03-05 |
California Institute Of Technology |
Diagnosis and treatment of autism spectrum disorder
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
CA2917483A1
(en)
|
2013-07-09 |
2015-01-15 |
Stemina Biomarker Discovery, Inc. |
Biomarkers of autism spectrum disorder
|
|
US20150294081A1
(en)
|
2014-04-11 |
2015-10-15 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
|
US9176113B1
(en)
|
2014-04-11 |
2015-11-03 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
|
US9758839B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
|
|
WO2016065075A1
(en)
|
2014-10-21 |
2016-04-28 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics
|
|
US10265009B2
(en)
|
2014-10-21 |
2019-04-23 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
|
|
WO2016069792A1
(en)
*
|
2014-10-30 |
2016-05-06 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
|
US10124025B2
(en)
|
2014-10-30 |
2018-11-13 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
|
AU2015339284B2
(en)
*
|
2014-10-30 |
2021-08-05 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
|
CN108138122B
(zh)
|
2014-12-23 |
2021-09-21 |
4D制药研究有限公司 |
免疫调控
|
|
BR112017013274A2
(pt)
|
2014-12-23 |
2018-02-06 |
4D Pharma Research Limited |
polipeptídeo e imunomodulação
|
|
JP6611156B2
(ja)
*
|
2015-01-30 |
2019-11-27 |
史郎 栃谷 |
妊娠期母体腸内細菌攪乱による行動異常モデル動物の作製方法とその用途
|
|
US10525020B2
(en)
|
2015-02-11 |
2020-01-07 |
Laboratory Corporation Of America Holdings |
Metabolic markers of attention deficit hyperactivity disorder
|
|
EP3268354B1
(en)
|
2015-03-13 |
2020-05-06 |
Mironova Innovations, LLC |
Nalpha, nalpha, nalpha-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
|
|
WO2016168354A1
(en)
*
|
2015-04-13 |
2016-10-20 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
|
|
CN107708716B
(zh)
*
|
2015-04-13 |
2022-12-06 |
普梭梅根公司 |
用于微生物组分类学特征相关的状况的微生物组来源的诊断和治疗的方法及系统
|
|
WO2016168316A1
(en)
*
|
2015-04-13 |
2016-10-20 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
|
WO2016183577A1
(en)
|
2015-05-14 |
2016-11-17 |
Crestovo Llc |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
CN114470009A
(zh)
*
|
2015-05-22 |
2022-05-13 |
亚利桑那大学董事会 |
用于治疗自闭症谱系障碍及相关症状的方法
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
ME03511B
(me)
|
2015-06-15 |
2020-04-20 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
PT3307288T
(pt)
|
2015-06-15 |
2019-10-17 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
|
HRP20191949T1
(hr)
|
2015-06-15 |
2020-01-24 |
4D Pharma Research Limited |
Blautia stercosis i wexlerae za upotrebu u liječenju upalnih i autoimunih bolesti
|
|
CN105213433A
(zh)
*
|
2015-11-06 |
2016-01-06 |
王益超 |
一种用于治疗孤独症、复发性流产和不孕症的组合物
|
|
SI3209310T1
(en)
|
2015-11-20 |
2018-06-29 |
4D Pharma Research Limited |
Compositions containing bacterial strains
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
CN105543369B
(zh)
*
|
2016-01-13 |
2020-07-14 |
金锋 |
精神障碍的生物标志物及其应用
|
|
RS58869B1
(sr)
|
2016-03-04 |
2019-08-30 |
4D Pharma Plc |
Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
|
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
WO2017197252A1
(en)
*
|
2016-05-13 |
2017-11-16 |
Stemina Biomarker Discovery, Inc. |
Autism subsets
|
|
EP3465212A4
(en)
|
2016-05-23 |
2020-01-08 |
California Institute of Technology |
REGULAR FLORAL REGULATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商４Ｄ製藥有限公司 |
包含細菌菌株之組合物
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
CN117169508A
(zh)
|
2016-09-16 |
2023-12-05 |
武田药品工业株式会社 |
用于与接触活化系统相关的疾病的代谢产物生物标记
|
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018089794A1
(en)
*
|
2016-11-11 |
2018-05-17 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions for changing metabolite levels in a subject
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
WO2018109665A1
(en)
*
|
2016-12-15 |
2018-06-21 |
Nestec Sa |
Compositions and methods that modulate bacteria in a companion animal
|
|
WO2018148220A1
(en)
*
|
2017-02-07 |
2018-08-16 |
California Institute Of Technology |
Modulation of gut microbiota in huntington's disease and rett syndrome
|
|
EP3580700A4
(en)
*
|
2017-02-09 |
2020-11-18 |
Cognoa, Inc. |
PLATFORM AND SYSTEM FOR DIGITAL PERSONALIZED MEDICINE
|
|
KR20190122710A
(ko)
*
|
2017-02-14 |
2019-10-30 |
캘리포니아 인스티튜트 오브 테크놀로지 |
행동 및 질환에서의 4-에틸페놀 및 4-에틸페놀 술페이트의 미생물적 합성의 조정
|
|
CN110944650B
(zh)
*
|
2017-03-31 |
2022-03-04 |
轴向治疗公司 |
用于治疗和预防孤独症及相关障碍的肠选择性螯合剂
|
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
|
US11433102B2
(en)
|
2017-04-05 |
2022-09-06 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating Parkinson's disease (PD) and related disorders
|
|
EP3624782A4
(en)
|
2017-05-15 |
2021-05-05 |
Axial Biotherapeutics, Inc. |
MICROBIAL INDUCED AMYLOID INHIBITORS
|
|
EP3630137B1
(en)
|
2017-05-22 |
2023-05-17 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
TW201907931A
(zh)
|
2017-05-24 |
2019-03-01 |
英商4D製藥研究有限公司 |
包含細菌菌株之組合物
|
|
WO2018216912A1
(ko)
*
|
2017-05-26 |
2018-11-29 |
주식회사 엠디헬스케어 |
세균 메타게놈 분석을 통한 자폐증 진단방법
|
|
JP2020521760A
(ja)
|
2017-05-26 |
2020-07-27 |
クレストヴォ・ホールディングス・エルエルシー |
糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
|
|
PL3638271T3
(pl)
|
2017-06-14 |
2021-03-22 |
4D Pharma Research Limited |
Kompozycje zawierające szczepy bakteryjne
|
|
HUE059249T2
(hu)
|
2017-06-14 |
2022-11-28 |
4D Pharma Res Limited |
Baktériumtörzseket tartalmazó készítmények
|
|
SG11201912105PA
(en)
|
2017-06-14 |
2020-01-30 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
US10939862B2
(en)
*
|
2017-07-05 |
2021-03-09 |
Yusuf Ozgur Cakmak |
System for monitoring auditory startle response
|
|
US11883155B2
(en)
|
2017-07-05 |
2024-01-30 |
Yusuf Ozgur Cakmak |
System for monitoring auditory startle response
|
|
US11141089B2
(en)
*
|
2017-07-05 |
2021-10-12 |
Yusuf Ozgur Cakmak |
System for monitoring auditory startle response
|
|
US11447811B2
(en)
|
2017-07-17 |
2022-09-20 |
smartDNA Pty Ltd |
Method of diagnosing a dysbiosis
|
|
US11865145B2
(en)
|
2017-08-07 |
2024-01-09 |
Finch Therapeutics Holdings Llc |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
|
US20230158084A1
(en)
*
|
2018-01-05 |
2023-05-25 |
California Institute Of Technology |
Probiotics, metabolites, and uses thereof
|
|
CN113453698A
(zh)
|
2018-03-22 |
2021-09-28 |
阿黛尔医药简易股份公司 |
微生物组合物的新用途
|
|
US20210269860A1
(en)
*
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
|
CN109142744A
(zh)
*
|
2018-07-26 |
2019-01-04 |
珠海中科先进技术研究院有限公司 |
一种自闭症谱系障碍诊断试剂盒
|
|
WO2020069280A1
(en)
|
2018-09-27 |
2020-04-02 |
Crestovo Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
|
US12474327B2
(en)
|
2018-11-06 |
2025-11-18 |
Stalicla Sa |
Metabolic profiling for the diagnosis of a subset of idiopathic autism spectrum disorder patients, ADS Phenotype 1
|
|
US11676719B2
(en)
*
|
2018-12-20 |
2023-06-13 |
Oregon Health & Science University |
Subtyping heterogeneous disorders using functional random forest models
|
|
CN109706235A
(zh)
*
|
2019-01-29 |
2019-05-03 |
广州康昕瑞基因健康科技有限公司 |
一种肠道微生物菌群的检测和分析方法及其系统
|
|
US20220214358A1
(en)
|
2019-04-05 |
2022-07-07 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Diagnostic for childhood risk of autism spectrum disorder
|
|
EP3948277A4
(en)
*
|
2019-04-05 |
2023-05-24 |
Arizona Board of Regents on behalf of Arizona State University |
METABOLITES AS DIAGNOSTICS OF AUTISTIC SPECTRUM DISEASE IN CHILDREN WITH GASTROINTESTINAL SYMPTOMS
|
|
WO2020215219A1
(zh)
*
|
2019-04-23 |
2020-10-29 |
中国医学科学院北京协和医院 |
基于机器学习的使用代谢物作为标记物的孤独症谱系障碍诊断方法和装置
|
|
EP3965820A4
(en)
*
|
2019-05-07 |
2023-02-08 |
The Regents of the University of California |
COMPOSITIONS AND METHODS TO PROMOTE HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY
|
|
CN110178787B
(zh)
*
|
2019-05-08 |
2022-03-22 |
河南中医药大学 |
一种运用粪菌移植法建立自闭症大鼠模型的方法
|
|
JP2022541795A
(ja)
|
2019-07-19 |
2022-09-27 |
フィンチ セラピューティクス ホールディングス エルエルシー |
胃腸障害の治療のための方法および産物
|
|
WO2021072351A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Stemina Biomarker Discovery, Inc. |
Diagnosis and treatment of autism spectrum disorders using altered ratios of metabolite concentrations
|
|
PH12022550966A1
(en)
|
2019-10-21 |
2023-09-25 |
Biofermin Pharmaceutical Co Ltd |
Uremic toxin reducing agent
|
|
WO2021081247A1
(en)
*
|
2019-10-22 |
2021-04-29 |
Cornell University |
Microbiota based therapies to promote mental health
|
|
AU2019478845B2
(en)
*
|
2019-12-19 |
2024-09-05 |
Hill's Pet Nutrition, Inc. |
Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate in canines using tomato pomace and methods of identifying canines at risk of such conditions
|
|
US20230145281A1
(en)
*
|
2020-03-06 |
2023-05-11 |
University Of Virginia Patent Foundation |
System and method for predicting risk of diagnosis for autism spectrum disorder using neonatal analytics
|
|
CN111455076B
(zh)
*
|
2020-04-17 |
2022-10-21 |
济南市儿童医院 |
用于儿童孤独症评估的口腔菌群微生物
|
|
KR20230074216A
(ko)
*
|
2020-09-21 |
2023-05-26 |
몰레큘러 유 코포레이션 |
자폐 스펙트럼 장애의 진단 및 치료 방법
|
|
CN116547520A
(zh)
*
|
2020-09-21 |
2023-08-04 |
分子优公司 |
孤独症谱系障碍的诊断与治疗方法
|
|
WO2022087030A1
(en)
*
|
2020-10-19 |
2022-04-28 |
Second Genome, Inc. |
Methods for treating autism spectrum disorder
|
|
CN114544826B
(zh)
*
|
2020-11-24 |
2023-12-08 |
重庆医科大学 |
检测血浆中组氨酸的试剂在制备抑郁症检测试剂盒中的用途
|
|
EP4012414A1
(en)
|
2020-12-11 |
2022-06-15 |
Stalicla S.A. |
Diagnosis of autism spectrum disorder phenotype 1
|
|
CN113069469B
(zh)
*
|
2021-04-07 |
2022-12-13 |
上海市精神卫生中心（上海市心理咨询培训中心） |
调节性t细胞在制备治疗孤独症药物或细胞疗法中的应用
|
|
CN114699423B
(zh)
*
|
2022-02-16 |
2023-06-23 |
广州知易生物科技有限公司 |
脆弱拟杆菌的荚膜多糖提取物在制备防治精神分裂症的药物中的应用
|
|
CN114699424B
(zh)
*
|
2022-02-16 |
2023-07-18 |
广州知易生物科技有限公司 |
脆弱拟杆菌两性离子荚膜多糖或/和改性的两性离子荚膜多糖的新应用
|
|
CN114457153A
(zh)
*
|
2022-03-15 |
2022-05-10 |
西安交通大学 |
一种孤独症血清神经元来源外泌体标志物chrm1的应用
|
|
CN114689747A
(zh)
*
|
2022-03-25 |
2022-07-01 |
天津中医药大学 |
咪唑丙酸作为生物标志物用于预测溃疡性结肠炎的应用以及成套用具
|
|
CN114622026B
(zh)
*
|
2022-04-02 |
2024-10-01 |
中南大学湘雅三医院 |
拟杆菌作为预测自闭症疗效的客观指标
|
|
CN116990395A
(zh)
*
|
2022-04-26 |
2023-11-03 |
中国科学院深圳先进技术研究院 |
一种基于粪便的阿尔兹海默症生物标志物及其应用
|
|
CN115368300B
(zh)
*
|
2022-10-27 |
2023-03-24 |
北京拓领博泰生物科技有限公司 |
用于tlr8抑制剂的化合物及其制备方法、应用
|
|
CN115616227B
(zh)
*
|
2022-11-18 |
2023-05-16 |
四川大学华西医院 |
吲哚-3-丙烯酰甘氨酸检测试剂的用途、诊断或辅助诊断慢性阻塞性肺病的试剂盒及系统
|
|
US12005044B1
(en)
|
2022-11-29 |
2024-06-11 |
Autism Therapeutics Inc. |
Treatment of autism spectrum disorders with ergothioneine, selenoneine, or combinations thereof
|
|
WO2025007066A1
(en)
*
|
2023-06-30 |
2025-01-02 |
University Of Massachusetts |
Biomarkers and methods related to fragile x syndrome
|